HMGB1 May Be a Biomarker for Predicting the Outcome in Patients with Polymyositis /Dermatomyositis with Interstitial Lung Disease

OBJECTIVE: To investigate the significance of high mobility group box 1 (HMGB1) levels in polymyositis (PM) and dermatomyositis (DM) patients with interstitial lung disease and whether HMGB1 levels could predict disease outcome. METHODS: HMGB1 levels were measured in sera from 34 patients with PM/DM...

Descripción completa

Detalles Bibliográficos
Autores principales: Shu, Xiaoming, Peng, Qinglin, Lu, Xin, Wang, Guochun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990180/
https://www.ncbi.nlm.nih.gov/pubmed/27537498
http://dx.doi.org/10.1371/journal.pone.0161436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990180/
https://www.ncbi.nlm.nih.gov/pubmed/27537498
http://dx.doi.org/10.1371/journal.pone.0161436

Ejemplares similares